Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) is now available.
Shandong Weigao Group Medical Polymer Company Limited has announced the composition of its board of directors and their respective roles. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic direction and operational oversight, which is crucial for stakeholders and investors.
The most recent analyst rating on (HK:1066) stock is a Buy with a HK$6.40 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. The company operates in the medical polymer industry, focusing on the production and distribution of medical devices and related products.
Average Trading Volume: 10,817,723
Technical Sentiment Signal: Hold
Current Market Cap: HK$25.55B
For a thorough assessment of 1066 stock, go to TipRanks’ Stock Analysis page.